2022 | LATE-BREAKING ABSTRACT PRESENTATION: COMPARATIVE EFFECTIVENESS OF HIPEC FOLLOWING INTERVAL CYTOREDUCTIVE SURGERY IN PATIENTS WITH ADVANCED-STAGE OVARIAN CANCER UNDERGOING NEOADJUVANT CHEMOTHERAPY: MULTICENTER, PROSPECTIVE, COHORT STUDY (KGOG 3042) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | OREGOVOMAB AND NON-PLATINUM SINGLE AGENT CHEMOTHERAPY IN PARP INHIBITOR-RESISTANT OVARIAN CANCER PATIENTS NOT CANDIDATE FOR PLATINUM RETREATMENT: A MULTI-COHORT PHASE II STUDY (KGOG 3065/APGOT-OV6) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | PATIENT-DERIVED ORGANOIDS AS A PRECLINICAL PLATFORM FOR PRECISION MEDICINE IN PATIENTS WITH CERVICAL CANCER | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | PREDICTION OF SURGICAL OUTCOMES OF INTERVAL DEBULKING SURGERY (IDS) USING IN ADVANCED OVARIAN CANCER: A NOVEL SCORING SYSTEM USING POST-NEOADJUVANT CHEMOTHERAPY (NAC) COMPUTED TOMOGRAPHY (CT) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2019 | Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced-stage ovarian cancer
| CANCER MEDICINE |
2019 | Prognostic significance of CA-125 re-elevation after interval debulking surgery in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy | EJSO |
2022 | PROPENSITY SCORE-MATCHED COMPARISON OF PERIOPERATIVE OUTCOMES USING DA VINCI XI AND SP SURGICAL SYSTEM IN ENDOMETRIAL CANCER SURGICAL STAGING | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | Quenching Epigenetic Drug Resistance Using Antihypoxic Microparticles in Glioblastoma Patient-Derived Chips | ADVANCED HEALTHCARE MATERIALS |
2022 | RE-VALIDATION OF CHEMOTHERAPY RESPONSE SCORE (CRS) AS A PROGNOSTIC FACTOR IN OVARIAN CANCER: THE EFFECT OF BEVACIZUMAB AND HIPEC ON SURVIVAL | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2019 | Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041) | GYNECOLOGIC ONCOLOGY |
2019 | Real-World Experience of Olaparib Maintenance in High-Grade Serous Recurrent Ovarian Cancer Patients with BRCA1/2 Mutation: A Korean Multicenter Study
| JOURNAL OF CLINICAL MEDICINE |
2020 | Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer: A Korean Multi-Center Retrospective Study (KGOG1041)
| CANCERS |
2020 | Rethinking Radical Surgery in Interval Debulking Surgery for Advanced-Stage Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy
| JOURNAL OF CLINICAL MEDICINE |
2023 | Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2023 | Secondary cytoreductive surgery with and without hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer
| GLAND SURGERY |
2024 | Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian Cancer | CANCER RESEARCH |
2022 | Therapeutic Efficacy of Catheter-directed Ethanol Sclerotherapy and Its Impact on Ovarian Reserve in Patients with Ovarian Endometrioma at Risk of Decreased Ovarian Reserve: A Preliminary Study | JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY |
2018 | Transcatheter Arterial Embolization for Severe Secondary Hemorrhage after Hysterectomy | JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY |
2018 | Two-step sentinel lymph node mapping strategy in endometrial cancer staging using fluorescent imaging: A novel sentinel lymph node tracer injection procedure | SURGICAL ONCOLOGY-OXFORD |
2022 | Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity? | GYNECOLOGIC ONCOLOGY |
2022 | USEFULNESS OF PRE-OPERATIVE PET-CT IN PATIENTS WITH ENDOMETRIAL CANCER UNDERGOING SENTINEL LYMPH NODE MAPPING: DO NEGATIVE FINDINGS ON PET-CT NEGATIVITY REALLY INDICATE NODE NEGATIVITY? | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2020 | 복강경하 전자궁절제술의 예방적 항생제로 사용한 Cefotetan과 Cefotiam의 효과 비교
| Journal of Surgical Infection (대한수술감염학회지) |